Cephalon receives FDA approval for Risk Evaluation and Mitigation Strategy for FENTORA and ACTIQ
21 July 2011 | By Cephalon, Inc.
The FDA approved the Risk Evaluation and Mitigation Strategy for FENTORA® & ACTIQ®...
List view / Grid view
News
GlaxoSmithKline European regulatory update on Pandemrix™
21 July 2011 | By GlaxoSmithKline
The EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended an update to the product label, Pandemrix...
Bristol-Myers Squibb to acquire Amira Pharmaceuticals
21 July 2011 | By Bristol-Myers Squibb
Bristol-Myers Squibb will acquire privately held Amira Pharmaceuticals, a small-molecule pharmaceutical company...
Merck and Simcere sign agreement to establish pioneering China joint venture
21 July 2011 | By Merck
Merck & Co., Inc., and Simcere announced the signing of a framework agreement to establish a joint venture...
Brecon appoints new Director of Operations
21 July 2011 | By AD Communications Ltd
Brecon Pharmaceuticals, has appointed Charles Evans to the role of operations director...
Novozymes Biopharma secures business innovation award
21 July 2011 | By The Scott Partnership
Novozymes Biopharma, received the 2011 NEP Business Award...
FDA Advisory Committee recommends approval of Remicade®
21 July 2011 | By
The Gastrointestinal Drugs Advisory Committee (GIDAC) of the U.S. FDA recommended the approval of REMICADE® (infliximab)...
Pfizer to acquire Icagen
20 July 2011 | By Pfizer
Pfizer Inc. and Icagen, Inc. announced that they have entered into a definitive merger agreement....
FDA approves new medicine BRILINTA (ticagrelor) for use in the US
20 July 2011 | By AstraZeneca
The US FDA has approved BRILINTA (ticagrelor) tablets...
Merck and Roche expand agreement in fight against chronic hepatitis C
20 July 2011 | By Merck
Merck has signed a new non-exclusive agreement with Roche...
FDA Advisory Committee makes recommendation on investigational compound dapagliflozin
20 July 2011 | By AstraZeneca
FDA Endocrinologic and Metabolic Drugs Advisory Committee meeting outcome...
Idera Reports Clinical Hold on Proposed Phase 2 Clinical Trial of IMO-3100
20 July 2011 | By Idera Pharmaceuticals
Idera Pharmaceuticals announced the receipt of a verbal communication from the U.S. FDA that a proposed Phase 2 protocol...
Thermo Fisher Scientific wins R&D 100 award with UV-Vis Spectrophotometer
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its Evolution 200 series of next-generation UV-Visible spectrophotometers featuring INSIGHT and CUE (Customized User Environment) software has been named one of the most technologically significant products of the past 12 months by R&D Magazine.
Optibrium Launches New Version of Free StarVue App
19 July 2011 | By The Scott Partnership
Optibrium launches a new version of StarVue...
Sigma® Life Science Launches CompoZr® Targeted Integration Kit – mRosa26 for the Mouse Genome
19 July 2011 | By kdm communications limited
Sigma Life Science, announced the launch of CompoZr Targeted Integration Kit – mRosa26...
